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Introduction
Rice is the staple diet for more than half the popula-
tion of the world (Khush et al. 1984), and globally
nearly 10–15% of rice yield is lost because of diseases
caused by phytopathogens (Ou 1985). Among these dis-
eases, rice blast caused by Magnaporthe grisea (Herbert)
Barr (anamorph. Pyricularia grisea, Sacc. formerly P.
grisea), is considered to be the most serious and
widely distributed disease (Ou 1972; Mew 1991).
Although efforts are being made to control the disease,
alternative approaches and new bioactive compounds
need to be used to control plant diseases to reduce the
negative environmental impact because of the use of
chemicals.
Microbial compounds exhibiting antagonistic activities
include a wide variety of surface and interfacially active
compounds, such as glycolipids, lipopeptides, polysaccha-
ride–protein complexes, phospholipids, fatty acids and
neutral lipids; however, among the many classes of biosurf-
actants, lipopeptides are particularly interesting because of
their high surface activities and antagonistic potential
(Georgiou et al. 1992; Neu 1996; Ron and Rosenberg 2001;
Kim et al. 2004). The consequences of the interaction of
these compounds with eukaryotic cells are well known and
include pyrogenicity, toxicity, immunogenicity and other
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Abstract
Aims: Isolation of bacterial antagonist for use in the biological control of phy-
topathogenic fungi like rice blast fungus, Magnaporthe grisea, and to further
purify and characterize the antifungal molecule produced by the antagonist.
Methods and Results: Bacterial antagonist exhibiting highest antifungal activity
against the rice blast fungus M. grisea was isolated from soil and identified as
Bacillus licheniformis BC98. Besides M. grisea, the isolate also inhibited the
growth of other phytopathogens such as Curvularia lunata and Rhizoctonia ba-
taticola. Biologically active fractions were isolated from the culture filtrate and
further fractionated by reverse-phase high-performance liquid chromatography
(HPLC) enabling detailed structural characterization of a component of molec-
ular mass 1035 Da. The active peptide was identified as surfactin after
500 MHz 1H NMR analysis. Microscopic analysis of the effect of the antagonist
on M. grisea revealed bulbous hyphae showing patchy and vacuolated cyto-
plasm when observed under the electron microscope.
Conclusions: The antagonistic lipopeptide secreted by B. licheniformis BC98
and identified as surfactin, induced morphological changes in M. grisea, inhib-
iting its further growth, and thus exhibiting fungicidal activity.
Significance and Impact of the Study: The antagonist inhibits germination of
M. grisea, a potent rice phytopathogen, and therefore appears to be a potential
candidate for control of rice blast disease.
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molecular effects (Wicken and Knox 1980). Moreover,
biosurfactants are easily biodegradable and less toxic than
chemical surfactants, and thus are particularly suited for
environmental and agricultural applications (Ron and
Rosenberg 2001; Kim et al. 2004).
Biosurfactants are produced by a wide variety of
diverse micro-organisms. Various bacterial species like
Enterobacter (Chernin et al. 1995), Pseudomonas (Levy
et al. 1992; Ganeshan and Kumar 2005), Bacillus (Javaheri
et al. 1985; Cooper and Goldenberg 1987; Rosales et al.
1993; Peypoux et al. 1999), Streptomyces (Gomes et al.
2001) and Erwinia (Bryk et al. 1998) have been described
as producers of effective biological control agents antago-
nistic to many fungal phytopathogens. However, data per-
taining to the antagonistic activity of bacteria against M.
grisea, a potent rice pathogen, are still restricted to only a
few strains of Pseudomonas (Lee et al. 2003), Streptomyces
(Gomes et al. 2001) and Bacillus (Cottyn et al. 2001). In
view of this, the aim of the study was to investigate bacte-
rial isolates from soil for their antagonistic activity for use
in the biological control of phytopathogenic fungi like M.
grisea. The bacterial antagonist was identified, and the
biocontrol agent produced by the antagonist was purified,
characterized and examined for fungicidal activity against
M. grisea and other phytopathogens.
Materials and methods
Fungal strains
Sclerotium sclerotinii, Phomopsis phyllanthi, Rhizoctonia
bataticola, Aspergillus niger N 573, Curvularia lunata, Hel-
minthosporium sp., Chaetomium sp., Fusarium verticillio-
ides, Pestaliopsis magnifera, Gleosporium magnifera were
kindly provided by the strain collection centre of Hans-
Kno¨ll-Institut fu¨r Naturstoff-Forschung, Jena. Magnapor-
the grisea B157 was isolated in our laboratory from
infected rice leaves (Kachroo et al. 1994). Fungal cultures
were grown and maintained on YEG medium (glucose
10 g l–1, yeast extract 2 g l–1) or oat meal agar (Hi Media,
Mumbai, India). Fungal conidia were harvested by scrap-
ing the biomass grown on oat meal agar plates with a
sterile surgical blade, resuspended in sterile water and
purified by passing through glass wool column.
Isolation of bacterial antagonist
One gram of each soil sample, collected from different
locations in Gujarat, India, was suspended in 10 ml of
sterile water and vortexed for 45 s. The sample was seri-
ally diluted and 100 ll of each dilution was added to
molten YEG agar maintained at 55C along with 105
spores of M. grisea and poured in sterile petri dishes.
After incubation at 28C for 2–3 days, bacterial colonies
showing zones of inhibition were selected and transferred
to fresh YEG agar medium. Further, the bacterial antago-
nists were grown in Luria-Bertani broth (LB) (Hi Media)
at 28C, 200 rev min–1 for 48 h. The supernatant was
separated by centrifugation at 13 000 g for 10 min fol-
lowed by filtration through 0Æ45-lm filter (Millipore,
Schwalbach, Germany) to remove bacteria (crude super-
natant). Further, the supernatant was concentrated
10-fold by lyophilization and used for confirming anti-
fungal activity on a test plate. Nystatin (Sigma, St Louis,
MO, USA) was used as a positive control at a concentra-
tion of 5Æ7 U ml–1. Long-term storage of bacterial isolates
was performed either on LB slants or in glycerol (stored
at –80C).
Test plate for checking the activity of the bacterial
antagonists was prepared by mixing M. grisea conidia
(105 spores ml–1) with molten YEG agar maintained at
55C and then poured in sterile petri plates. Concentrated
culture supernatant (10-fold) was added in the wells,
made in YEG agar using sterile metal cylinders, and the
plates were incubated at 28C for 48 h.
For further analysis, fungal strains were inoculated
(106 conidia) and grown in 50 ml of YEG medium for
2 days at 28C, 200 rev min–1 in the presence or absence
of the culture supernatant (1% v ⁄ v) of antagonist bacte-
rial, grown in LB for 48 h at 28C. The biomass was
separated, dried at 105C for 14 h and weighed to
obtain the dry weight. The dry weight of treated bio-
mass (fungus grown in the presence of the antagonist)
was subtracted from the control biomass (fungal bio-
mass grown in the absence of the antagonist) and the
values were expressed in percentage in order to obtain
reduction in biomass of the aforementioned fungal
strains.
Identification of bacterial antagonist
The bacterial antagonist showing highest antifungal
activity was identified by the Biolog system (Mauchline
and Keevil 1991), and by 16S rRNA gene sequence anal-
ysis. Polymerase chain reaction (PCR) amplification of
16S rRNA gene was carried out using the Eubacteria-
specific primers 19 F (5¢-AGAGTTTGATCCTGGCTCA-
3¢) and 20R (5¢-GCTCGTTGCGGGACTTATCC-3¢). The
thermal cycle used was as follows: initial denaturation at
94C for 3 min followed by 30 cycles of 94C, 30 s;
58C, 30 s and 72C, 1 min; in a Minicycler (MJ
Research, Waltham, MA, USA). The final step included
final elongation at 72C for 5 min. Amplified PCR prod-
uct was purified and sequenced with CEQ 8000 series
Genetic Analysis System (Beckman Coulter, Fullerton,
CA).
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Sensitivity of the culture supernatant of Bacillus
licheniformis BC98 to proteolytic enzymes, surfactants,
heat and pH
The concentrated crude supernatant (15 ll) was subjected
to treatments for 2 h at 37C (for enzymes) or room
temperature (for surfactants). The proteolytic enzymes
(Sigma) were used at a final concentration of 1 mg ml–1
in 10 mmol–1 potassium phosphate buffer, pH 7Æ0. The
concentrate crude supernatant in buffer without enzymes
as well as the enzyme solutions was exposed to the same
conditions. The surfactants used were sodium dodecyl
sulfate (SDS), Tween 80, Triton X-100 and urea, which
were used at a final concentration of 1% (v ⁄ v) and incu-
bated at 37C for 5 h. All surfactants (Sigma) were pre-
pared at 10% in water and filter-sterilized before use. For
the heat treatment, the preparations were incubated at
25C or heated at 37C, and 60C and autoclaved (121C,
15 min). For pH stability, 10 ll of concentrated superna-
tants were mixed to the same volume of citric acid–
Na2HPO4 buffer to achieve different pH values lower
than 6Æ0 and with Tris-HCl buffer for pH 8Æ0 and 10Æ0.
Antifungal activities were checked before and after all
treatments on a test plate made with M. grisea conidia as
mentioned earlier.
Purification and characterization of bulb-inducing
compound
Media and process parameters for better production
and purification of antifungal molecule from B. licheni-
formis were performed as reported (Patel et al. 2004).
For large-scale production of the antifungal molecule
for purification and characterization, B. licheniformis
BC98 was grown in CYD medium (glucose 1% w ⁄ v,
casein enzyme hydrolysate 1% w ⁄ v, KH2PO4 0Æ5% w ⁄ v,
yeast nitrogen base without amino acids and ammo-
nium sulfate 0Æ65% w ⁄ v) for 16 h at 28C at
200 rev min–1. The bacteria were separated from the
culture broth by centrifugation at 10 000 g for 10 min
at 4C. The antifungal peptides were extracted from the
supernatant with chloroform : methanol (9 : 1). The
combined organic extract was concentrated in vacuo
yielding a brownish gummy residue, which was further
purified by reverse-phase high-performance liquid chro-
matography (HPLC) (HP 1100; Hewlett-Packard, Palo
Alto, CA), on a Vydac C18 column, 250 mm · 10 mm,
4 lm. Purification was carried out using methanol–
water gradient containing 0Æ1% v ⁄ v TFA (triflouroacetic
acid), monitored at A226. A gradient of 65–75% in
20 min and 75–95% in 35 min was used with a flow
rate of 1Æ5 ml min–1. This protocol yielded 52 mg of
purified molecule from 20 l of culture supernatant.
MALDI-TOF-MS (matrix assisted laser desorption ⁄
ionization time-of-flight mass spectrometry) was carried
out on a Kompact SEQ spectrometer (Kratos Analytical,
Manchester, UK) operating with a N2 laser of 337 nm.
All of the analyses were carried out in the positive ion
mode. Spectra were averaged over 25 laser shots.
Matrix solution was prepared by dissolving a-cyano-4-
hydroxycinnamic acid powder (Sigma Aldrich Chemicals
Pvt. Ltd., Bangalore, India) in acetonitrile : water (1 : 1
v ⁄ v) with 0Æ1% (v ⁄ v) trifluoroacetic acid to obtain a satu-
rated solution. MALDI sample plates were first spotted
with 1 ll of matrix solution followed by 1 ll of sample
(0Æ1 mg ml–1). After air drying of the sample, one-dimen-
sional (1D) and 2D nuclear magnetic resonance (NMR)
experiments were carried out in CD3OH solvent (Sigma
Aldrich Chemicals Pvt. Ltd.) on a BRUKER-DRX-500
MHZ spectrometer. All experiments were performed at
323 K as it provided a better dispersion. Peptide concentra-
tion was c. 4 mmol l–1. Resonance assignments were per-
formed using the experiments. The TOCSY and ROESY 2D
data were collected in phase-sensitive mode. The spectral
widths were set to 6000 Hz. 16 K data points were used for
1D and for 2D, sets of 1024 and 450 data points were used
in t2 and t1 dimensions, respectively. For TOCSY and
ROESY, 32 and 64 transients were collected, respectively
for each increment of 2D data set. Final data matrix size
after zero filling was 2 K · 1 K. A shifted square sine-bell
window was used before Fourier transformation.
Detection of in vitro antifungal activity
In order to determine inhibitory activity of the antagonis-
tic molecule against M. grisea, 100 ll of spore suspension
(104 spores ml–1) of M. grisea was allowed to germinate
on a glass slide under high humidity in presence of 0Æ1,
1Æ0 and 10 lg ml–1 concentrations of purified antifungal
compound. The germination of spores was allowed at
28C for 24 h and change in morphology was monitored
microscopically. The experiment was repeated twice and
each time it was performed in triplicate.
Microscopy
Light microscopy images were taken with the help of
Nikon eclipse E1000 equipped with DXM1200 CCD
camera (Nikon, Japan). Effect of antifungal molecule on
M. grisea spores was observed by germinating 103 spores
in the presence or absence of 0Æ1 lg ml–1 of antifungal
compound on glass slides.
For electron microscopic studies, 105 spores of M. gri-
sea were inoculated in 50 ml of YEG medium and grown
at 28C and 200 rev min–1. After 48 h, the biomass
obtained was further incubated with 0Æ1 lg ml–1 of
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bulb-inducing compound (BIC) under the aforemen-
tioned conditions for 2 h and embedded in 0Æ2 % w ⁄ v
agarose and cut into 2-mm2 blocks. Samples were fixed in
4% glutaraldehyde in 50 mmol l–1 of cacodylate buffer,
pH 7Æ2; for 2 h, followed by three cacodylate buffer
washes of 10 min each. Further fixing was performed in
osmium tetroxide (1% w ⁄ v) overnight at 28C. The sam-
ples were washed four times in buffer followed by dehy-
dration in ethanol of increasing concentration (10%,
30%, 50%, 70%, 95%, 100%; v ⁄ v), ethanol : acetone
(1 : 1) and 100% acetone. Infiltration of spur was per-
formed in acetone, and finally sample, was embedded in
fresh 100% spur at 70C overnight. One-micron sections
were observed under the microscope. Ultra-thin sections
were prepared by ultramicrotome (Jeol JEM, Tokyo,
Japan). The sections were mounted in 200 mesh Formvar
coated copper grids (Sigma Aldrich Chemicals Pvt. Ltd.)
and were stained with 1% w ⁄ v lead citrate and 2% w ⁄ v
uranyl acetate and the grids were preserved under desic-
cation before observation under the electron microscope
(JEM-2500SE).
Nucleotide sequence accession number
The nucleotide sequence of 16S rDNA of B. licheniformis
strain BC98 has been deposited in the GenBank database
under the accession number EF545137.
Results
Screening and identification of bacterial antagonist
To screen for a potential bacterial antagonist, over 150
bacterial isolates from soil were screened for their ability
to inhibit the mycelial growth of rice blast fungus M. gri-
sea. Eight bacterial isolates showed significant antifungal
activity against this phytopathogen. Interestingly, bacterial
isolate I-6 not only showed the strongest inhibitory activ-
ity against the fungus, but also induced morphological
changes in M. grisea. The isolate was a facultative anaer-
obe, gram-positive, motile, endospore-former, growing at
65C and tolerated upto 10% NaCl. Using the Biolog sys-
tem and 16S rRNA gene analysis, the isolate was identi-
fied as belonging to the genus Bacillus. 16S rDNA
sequence analysis showed that this Bacillus strain had
100% similarity with B. licheniformis (Fig. 1), and was
designated as B. licheniformis BC98. Preliminary screening
to study the spectrum of fungal growth inhibition by
crude extracts from B. licheniformis BC98 showed that it
produced a potential antagonistic compound, which had
significant activity against different phytopathogenic fungi
including M. grisea (Table 1). Furthermore, the antifungal
activity was found to be highly stable at extreme pH and
temperatures, and also after treatments with pepsin, tryp-
sin and different detergents (Table 2).
Purification of the antifungal peptide
Assays for isolation of antifungal antagonists was devised
based on morphological changes induced in the germinat-
ing spores of M. grisea, leading to a number of bacterial
Bacillus pumilus EF032679
Bacillus thuringiensis AM419199
Bacillus cereus AM422128
Bacillus subtilis EF042283
Bacillus amyloliquefaciens EF423607
Bacillus licheniformis BC98
Bacillus sp. EF471917
Bacillus licheniformis AJ880758
546
1000
985
896
987
0·01
Figure 1 Neighbour-joining phylogenetic tree showing relationships
between strain BC98 and several other strains of Bacillus, based on their
16S rDNA sequences. Numbers at nodes represent the percentages of
occurrence of nodes in 1000 bootstrap trials. The scale bar represents
the expected number of substitutions per nucleotide position.
Table 1 Broad-spectrum antifungal activity of culture supernatant of
Bacillus licheniformis BC98 towards phytopathogenic fungi
Fungal phytopathogen
Reduction in
growth (%)*
Diameter of inhibition
zone (cm)**
Sclerotium sclerotinii 95Æ90 ± 2Æ3 2Æ5 ± 0Æ35
Phomopsis phyllanthi 83Æ90 ± 4Æ1 1Æ8 ± 0Æ23
Rhizoctonia bataticola 94Æ23 ± 2Æ6 2Æ3 ± 0Æ21
Aspergillus niger N 573 14Æ20 ± 1Æ9 1Æ1 ± 0Æ26
Curvularia lunata 98Æ11 ± 1Æ3 2Æ9 ± 0Æ41
Magnaporthe grisea 96Æ90 ± 2Æ7 2Æ7 ± 0Æ31
Helminthosporium sp. 97Æ64 ± 1Æ2 2Æ8 ± 0Æ25
Chaetomium sp. 91Æ10 ± 3Æ3 2Æ2 ± 0Æ31
Fusarium verticillioides 75Æ70 ± 4Æ2 1Æ7 ± 0Æ21
Pestaliopsis magnifera 95Æ90 ± 1Æ8 2Æ6 ± 0Æ32
Gleosporium magnefera 97Æ68 ± 1Æ3 2Æ6 ± 0Æ37
*The dry weight of treated biomass (fungus grown in the presence of
antagonist) was subtracted from the control biomass (fungal biomass
grown in the absence of antagonist) and expressed in percentage in
order to obtain reduction in biomass. The data represents the average
of three replicates.
**Data represents the average of three replications.
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antagonists, and one of these highly effective against devel-
opment of appressoria in this fungus, was selected for fur-
ther studies. The conditions for maximum yield of
antifungal peptide had been optimized earlier (Patel et al.
2004). The specific growth rate (l) was calculated to be
0Æ52 and the doubling time (tD) was found to be 80 min.
To purify the antifungal compound from the culture super-
natant of B. licheniformis was precipitated by adjusting
the pH with 3 N HCl and extracted using chloroform ⁄
methanol (2 : 1, v ⁄ v). Antifungal peptides soluble in chlo-
roform-methanol were readily extracted yielding a group of
microheterogeneous molecules with masses ranging from
992 to 1077 Da. Antagonistic activity was checked for each
fraction during chloroform : methanol purification. Two
major peaks were fractionated, and antifungal activity was
examined (Fig. 2). Peak of 1035-Da peptide showing anti-
fungal activity against phytopathogenic fungi, including
M. grisea, and was used for further study.
Effect of antifungal peptide on Magnaporthe grisea
When the induction of morphological changes was
assayed using culture supernatant, bulb formation in the
mycelia of M. grisea was observed after 8 h of growth,
indicating production of antifungal compound. To vali-
date that among the various lipopeptides produced by B.
licheniformis, the 1035-Da peptide was the one inducing
morphological changes, and inhibiting the growth of
fungus, we further studied the effect of the purified anti-
fungal compound on the germination of M. grisea. The
spores were germinated on glass slides in the presence or
absence of the BIC. Magnaporthe grisea formed appresso-
ria on the glass surface (Fig. 3a). BIC inhibited germina-
tion of M. grisea spores at concentration as low as
1 lg ml–1 (Table 3). Although fungus germinated at lower
concentrations of BIC, the germ tube formed was abnor-
mal (Fig. 3b). Light microscopic observations of the bul-
bous and swollen germinating spores and hyphal tips
revealed shrunken, granulated and vesicular cytoplasm as
compared with the hyaline, healthy cytoplasm of control
untreated hyphae. The swollen bulbous structure subse-
quent to treatment with BIC measured from 18 to 25 lm
in diameter, whereas normal fungal hyphae had a diame-
ter of 2–2Æ5 lm. The maximum bulb-inducing activity
observed was 68 bulbs per mm2.
Electron microscopic studies
For further analysis by electron microscopy, the treated
fungal samples were embedded in agarose; sections were
taken and observed under the microscope. The cell wall
of M. grisea hyphae treated with antifungal molecule was
thick and showed distinct cytoplasmic membrane. The
mitochondria were elongated by three- to fourfold, com-
pared with the control. In contrast to the cytoplasm of
untreated biomass, which was dense, homogenous and
uniformly distributed (Fig. 4a) cytoplasm of treated sam-
ples was distinctly granular, patchy, fibrous and vacuo-
lated (Fig. 4b). Moreover, the cytoplasmic membrane was
not very distinct. This indicated that treatment of
M. grisea with BIC led to unpolarized growth of the tip,
thereby inhibiting normal development of M. grisea.
Table 2 Sensitivity of culture supernatant of Bacillus licheniformis
BC98 to heat, pH, protease and surfactants
Treatment* Residual activity (%)
Control 98Æ20 ± 1Æ35
Heat
25C for 30 min 98Æ2 ± 1Æ05
37C for 30 min 97Æ3 ± 2Æ15
60C for 30 min 98Æ2 ± 1Æ12
Autoclaving (121C, 20 min) 96Æ5 ± 3Æ2
pH
02.0 98Æ6 ± 1Æ12
04.0 98Æ2 ± 1Æ45
06.0 97Æ6 ± 1Æ16
08.0 98Æ2 ± 1Æ32
10.0 97Æ9 ± 2Æ05
Enzymes**
Pepsin 98Æ6 ± 1Æ12
Trypsin 97Æ6 ± 2Æ14
Surfactant
SDS 96Æ9 ± 2Æ74
Triton X-100 97Æ2 ± 1Æ89
Tween 80 95Æ3 ± 3Æ12
*Tests were performed on the 10-fold concentrated supernatant of
B. licheniformis BC98.
**All enzymes were used at a final concentration of 1 mg ml–1.
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Figure 2 Fractionation of the crude chloroform methanol (9 : 1)
extract of the culture supernatant of Bacillus licheniformis BC98.
High-performance liquid chromatographic profile is RP C18, 65–95%
methanol water gradient. Masses of the individual component are
indicated above the peaks.
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Structural analysis
Mass spectral analysis
MALDI TOF ⁄MS was chosen initially to determine the
molecular mass. Inspection of the MALDI mass spectrum
of the crude peptide mixture revealed two major groups
of substances with masses centered around 1000 and
1400 Da (Fig. 5a). Within each group, the observed mi-
croheterogeneity corresponded to peaks related by mass
difference of 14 Da, indicating possible replacements of
–CH2– groups. This polypeptide fraction was further sep-
arated by reverse-phase HPLC, and one pure peptide with
a mass of 1035 Da was subjected to further characteriza-
tion by NMR analysis.
NMR analysis
500 MHz 1H NMR spectra in CD3OH showed seven dis-
tinct amide resonances establishing the presence of seven
amino acid residues (Fig. 5b). TOCSY and ROSEY spectra
enabled assignment of seven spin systems, Glu ⁄Gln (1),
Leu (4), Val (1), Asp ⁄Asn (Fig. 5c). The absence of pri-
mary amide –NH– resonance suggested that the residues
present were Glu and Asp. At this stage, the comparison
with the known sequences pointed to a similarity with
surfactin characterized earlier (Lin et al. 1994). Based on
(a)
(b)
10 µm
10 µm
Figure 3 Light microscopic studies on Magnaporthe grisea biomass
treated with the antifungal molecule. (a) Conidia germinated and
formed appressorial structure on glass surface. (b) Conidia germinated
in the presence of 0Æ1 lg ml–1 of purified antifungal compound. The
inhibition of further development of germ tube by antifungal mole-
cule inhibited appressoria formation as well as branched hyphae.
Table 3 Effect of purified bulb-inducing compound on germination
of phytopathogen, Magnaporthe grisea. The experiment was per-
formed in triplicate and repeated twice
Concentration (lg ml–1) Germination (%)* Bulb formation (%)**
0Æ0 98Æ2 ± 1Æ5 –**
0Æ1 95Æ3 ± 2Æ3 93Æ2 ± 1Æ3
1Æ0 – –
10Æ0 – –
*The conidia were germinated at 28C for 24 h under high humidity.
**No bulb formation observed.
(a)
(b)
1 µ m
1 µ m
M
V
Figure 4 Electron microscopic studies of Magnaporthe grisea treated
with the antifungal molecule. Control and biomass treated with anti-
fungal molecule was embedded in 0Æ2% agarose and stained as men-
tioned in Materials and methods. (a) Untreated biomass showing
normal distribution of cytoplasm, and subcellular organelle-like mito-
chondria. (b) M. grisea treated with 0Æ1 lg ml–1 of purified antifungal
compound. The treated hyphae were vacuolated and showed patchy,
granulated cytoplasm. The mitochondria were elongated and mor-
phology was lost. M, mitochondria; V, vacuolated cytoplasm.
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the observed mass, the fatty acid moiety was assigned as
3-hydroxy tetradecanoic acid. Thus, the inhibitory peptide
against M. grisea produced by B. licheniformis BC98 was
identified to be surfactin. This class of lipopeptides is clo-
sely related to the lichenysin which has been characterized
from B. licheniformis (Peypoux et al. 1999).
Discussion
Biological control using antagonists provides an alterna-
tive to the use of pesticides for controlling plant diseases.
Among 150 putative bacterial antagonists obtained,
detailed studies were carried out on a gram-positive,
motile, endospore-forming culture identified to be B. li-
cheniformis. In presence of the supernatant from B. lichen-
iformis BC98, M. grisea showed bulbous hyphae which
inhibited further development of the fungus. Further-
more, the activity of antagonistic lipopeptide was found
to be highly stable at extreme pH and temperature and it
was also resistant to protease treatment. Bacillus species
are known to produce various antibiotics and antifungal
compounds that inhibit phytopathogenic fungi (Katz and
Demain 1977; Kang et al. 1998; Hiradate et al. 2002; Yu
et al. 2002; Cho et al. 2003; Thaniyavarn et al. 2003;
Souto et al. 2004; Korenblum et al. 2005). Bacillus licheni-
formis, e.g. has been reported to produce different anti-
fungal molecules such as fungimycin M4 (3Æ4 kDa
hydrophilic peptide), which inhibits the growth of fungi
such as Sporothrix schenckii, and Microsporum canis (Scott
et al. 1987; Lebbadi et al. 1994).
In order to further characterize the effect of the antago-
nistic compound on M. grisea, microscopic studies were
performed. Scanning electron and optical microscopic
studies showed that the lipopeptide was capable of affect-
ing the development of the phytopathogenic fungus. Light
microscopic studies showed that hyphae of M. grisea trea-
ted with the purified antagonistic compound were 8–10-
fold larger in diameter. Thus, the treatment caused
abnormal germ tube formation and as a result the fungus
could not grow further to form appressoria, necessary for
penetration of the host tissue. Similar swelling at the
hyphal tips has been observed in case of Aspergillus nidu-
lans when treated with cytochalsin A, which is a known
inhibitor of actin polymerization (Torralba et al. 1998).
The cytoskeleton of M. grisea when treated with the anti-
fungal peptide had collapsed leading to unpolarized
growth at the tip of the hyphae. The results indicate that
the peptide affected the distribution of cytoskeletal ele-
ments, actin and tubulin, and as a consequence, direc-
tional growth of the fungus is lost, leading to a bulbous
morphology.
The inhibitory peptide from B. licheniformis was puri-
fied by solvent extraction and reverse-phase HPLC and
characterized by MALDI-TOF-MS and NMR analysis.
This antifungal peptide was identified to be a surfactin.
Although surfactin was discovered about 30 years ago,
there has been a revival of interest in this compound
recently, triggered by an increasing demand for effective
biosurfactants for difficult contemporary ecological prob-
lems. Earlier, lipopeptide bioemulsifier such as surfactin
had been reported from Bacillus species and the structure
was elucidated by 2D NMR analysis combined with
molecular modelling (Bonmatin et al. 1994). Surfactin has
also found wide applications in industries (Razafindra-
lambo et al. 1998) and medicine (Arima et al. 1968;
Kameda et al. 1972; Vollenbroich et al. 1997) and has
been shown to be active against prokaryotes, yeasts and
100
80
60
40
20
0
600
ppm 2·75 2·50 2·25 2·00 1·75 1·50 1·25 1·00
ppm 8·0
(c)
(b)
(a)
7·5
CO
CH2
CH3 CH
O L-Leu
L-LeuL-Glu
D-Leu
D-Leu
L-Asp
L-Val
7·0 6·5 6·0 5·5 5·0 4·5
0·75
676·1
1035·4
700 800 900
Mass/Charge
1000 1100 1200
(CH2)10 
Figure 5 Structural analysis of antagonistic peptide. (a) MALDI-TOF-
MS of the component corresponding to the high-performance liquid
chromatographic (HPLC) peak with a retention time of 51 min. (b) 1H
nuclear magnetic resonance (NMR) spectrum of HPLC fraction
(1035 Da) in CD3OH at 323 K. (c) TOCSY and ROSEY spectral assign-
ment of seven amino acid residues to the antagonistic lipopeptide
identified as surfactin.
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fungi (Jenny et al. 1991; Peypoux et al. 1999); however,
its activity against rice blast fungi M. grisea has not been
investigated earlier. Preliminary studies at the green house
level have also indicated protection of rice by purified
antifungal compound from B. licheniformis BC98 against
rice blast disease (data not shown).
Thus, in the present study we identified the antifungal
agent produced by B. licheniformis BC98 as an antagonist
to M. grisea as well as other phytopathogens. This lipo-
peptide was highly potent in its antagonistic activity as it
completely inhibited the growth of M. grisea at a concen-
tration as low as 1 lg ml–1. Therefore, we suggest that it
may be a potential bioactive agent that should be further
explored for field application.
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